Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Psychedelic drugs without the trip? This sensor could help seek them out

An easier way to identify non-hallucinogenic psychedelics could aid treatment for illnesses such as depression and PTSD.
  1. Ariana Remmel
    View author publications

    You can also search for this author in PubMed  Google Scholar

Scientists in search of psychedelic drug treatments have developed a way to determine whether a molecule is likely to cause hallucinations, without testing it on people or animals.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-021-01156-y

Updates & Corrections

  • Clarification 03 May 2021: An earlier version of this story implied that David Olson's team was responsible for the fluorescent sensor that indicates whether hallucinations occur. It was Lin Tian's team that designed the sensor.

References

  1. Dong, C. et al. Cell https://doi.org/10.1016/j.cell.2021.03.043 (2021).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links